Share-based Payment Arrangement, Expense of iBio, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
iBio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • iBio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $323,000, a 22% decline year-over-year.
  • iBio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1,438,000, a 12% decline year-over-year.
  • iBio, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $1,530,000, a 23% decline from 2024.
  • iBio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1,975,000, a 31% decline from 2023.
  • iBio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2,863,000, a 28% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

iBio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,438,000 $323,000 -$92,000 -22% 01 Jul 2025 30 Sep 2025 10-Q/A 17 Nov 2025 2026 Q1
Q2 2025 $1,530,000 $270,000 -$35,000 -11% 01 Apr 2025 30 Jun 2025 10-K 05 Sep 2025 2025 FY
Q1 2025 $1,565,000 $370,000 -$84,000 -19% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q3
Q4 2024 $1,649,000 $475,000 +$21,000 +4.6% 01 Oct 2024 31 Dec 2024 10-Q 10 Feb 2025 2025 Q2
Q3 2024 $1,628,000 $415,000 -$347,000 -46% 01 Jul 2024 30 Sep 2024 10-Q/A 17 Nov 2025 2026 Q1
Q2 2024 $1,975,000 $305,000 -$132,000 -30% 01 Apr 2024 30 Jun 2024 10-K 05 Sep 2025 2025 FY
Q1 2024 $2,107,000 $454,000 +$69,000 +18% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q3
Q4 2023 $2,038,000 $454,000 -$461,000 -50% 01 Oct 2023 31 Dec 2023 10-Q 10 Feb 2025 2025 Q2
Q3 2023 $2,499,000 $762,000 -$364,000 -32% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2025 Q1
Q2 2023 $2,863,000 $437,000 -$628,000 -59% 01 Apr 2023 30 Jun 2023 10-K/A 24 Sep 2024 2024 FY
Q1 2023 $3,491,000 $385,000 -$828,000 -68% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q3
Q4 2022 $4,319,000 $915,000 -$45,000 -4.7% 01 Oct 2022 31 Dec 2022 10-Q 09 Feb 2024 2024 Q2
Q3 2022 $4,364,000 $1,126,000 +$406,000 +56% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q2 2022 $3,958,000 $1,065,000 +$1,085,000 01 Apr 2022 30 Jun 2022 10-K 27 Sep 2023 2023 FY
Q1 2022 $2,873,000 $1,213,000 +$223,000 +23% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q3
Q4 2021 $2,650,000 $960,000 +$695,000 +262% 01 Oct 2021 31 Dec 2021 10-Q/A 19 May 2023 2023 Q2
Q3 2021 $1,955,000 $720,000 +$369,000 +105% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q1
Q2 2021 $1,586,000 $20,000 -$240,000 -109% 01 Apr 2021 30 Jun 2021 10-K 11 Oct 2022 2022 FY
Q1 2021 $1,826,000 $990,000 +$927,000 +1471% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q3
Q4 2020 $899,000 $265,000 +$228,000 +616% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q2
Q3 2020 $671,000 $351,000 +$283,000 +416% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2022 Q1
Q2 2020 $388,000 $220,000 +$161,000 +273% 01 Apr 2020 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q1 2020 $227,000 $63,000 +$14,000 +29% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q3
Q4 2019 $213,000 $37,000 -$23,000 -38% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021 2021 Q2
Q3 2019 $236,000 $68,000 -$5,000 -6.8% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2021 Q1
Q2 2019 $241,000 $59,000 -$134,000 -69% 01 Apr 2019 30 Jun 2019 10-K 13 Oct 2020 2020 FY
Q1 2019 $375,000 $49,000 -$134,000 -73% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q3
Q4 2018 $509,000 $60,000 -$129,000 -68% 01 Oct 2018 31 Dec 2018 10-Q 14 Feb 2020 2020 Q2
Q3 2018 $638,000 $73,000 -$132,000 -64% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2020 Q1
Q2 2018 $770,000 $193,000 -$104,000 -35% 01 Apr 2018 30 Jun 2018 10-K 26 Aug 2019 2019 FY
Q1 2018 $874,000 $183,000 -$24,000 -12% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q3
Q4 2017 $898,000 $189,000 -$52,000 -22% 01 Oct 2017 31 Dec 2017 10-Q 13 Feb 2019 2019 Q2
Q3 2017 $950,000 $205,000 -$60,000 -23% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2019 Q1
Q2 2017 $1,010,000 $297,000 -$28,000 -8.6% 01 Apr 2017 30 Jun 2017 10-K 18 Sep 2018 2018 FY
Q1 2017 $1,038,000 $207,000 -$90,000 -30% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q3
Q4 2016 $1,128,000 $241,000 -$73,000 -23% 01 Oct 2016 31 Dec 2016 10-Q 14 Feb 2018 2018 Q2
Q3 2016 $1,201,000 $265,000 -$64,000 -19% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q1
Q2 2016 $1,265,000 $325,000 +$101,000 +45% 01 Apr 2016 30 Jun 2016 10-K 15 Sep 2017 2017 FY
Q1 2016 $1,164,000 $297,000 +$73,000 +33% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q3
Q4 2015 $1,091,000 $314,000 +$101,000 +47% 01 Oct 2015 31 Dec 2015 10-Q 21 Feb 2017 2017 Q2
Q3 2015 $990,000 $329,000 +$76,000 +30% 01 Jul 2015 30 Sep 2015 10-Q 18 Nov 2016 2017 Q1
Q2 2015 $914,000 $224,000 -$16,000 -6.7% 01 Apr 2015 30 Jun 2015 10-K 13 Oct 2016 2016 FY
Q1 2015 $930,000 $224,000 -$101,000 -31% 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016 2016 Q3
Q4 2014 $1,031,000 $213,000 -$62,000 -23% 01 Oct 2014 31 Dec 2014 10-Q 22 Feb 2016 2016 Q2
Q3 2014 $1,093,000 $253,000 +$18,000 +7.7% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2016 Q1
Q2 2014 $1,075,000 $240,000 -$13,000 -5.1% 01 Apr 2014 30 Jun 2014 10-K 13 Oct 2015 2015 FY
Q1 2014 $1,088,000 $325,000 -$14,000 -4.1% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q3
Q4 2013 $1,102,000 $275,000 +$58,000 +27% 01 Oct 2013 31 Dec 2013 10-Q 24 Feb 2015 2015 Q2
Q3 2013 $1,044,000 $235,000 -$219,000 -48% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2015 Q1
Q2 2013 $1,263,000 $253,000 01 Apr 2013 30 Jun 2013 10-K 29 Sep 2014 2014 FY
Q1 2013 $339,000 -$272,948 -45% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q3
Q4 2012 $217,000 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014 2014 Q2
Q3 2012 $454,000 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2014 Q1
Q1 2012 $611,948 01 Jan 2012 31 Mar 2012 10-Q 20 May 2013 2013 Q3

iBio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,530,000 -$445,000 -23% 01 Jul 2024 30 Jun 2025 10-K 05 Sep 2025 2025 FY
2024 $1,975,000 -$888,000 -31% 01 Jul 2023 30 Jun 2024 10-K 05 Sep 2025 2025 FY
2023 $2,863,000 -$1,095,000 -28% 01 Jul 2022 30 Jun 2023 10-K/A 24 Sep 2024 2024 FY
2022 $3,958,000 +$2,372,000 +150% 01 Jul 2021 30 Jun 2022 10-K 27 Sep 2023 2023 FY
2021 $1,586,000 +$1,198,000 +309% 01 Jul 2020 30 Jun 2021 10-K 11 Oct 2022 2022 FY
2020 $388,000 +$147,000 +61% 01 Jul 2019 30 Jun 2020 10-K 28 Sep 2021 2021 FY
2019 $241,000 -$529,000 -69% 01 Jul 2018 30 Jun 2019 10-K 13 Oct 2020 2020 FY
2018 $770,000 -$240,000 -24% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2019 2019 FY
2017 $1,010,000 -$255,000 -20% 01 Jul 2016 30 Jun 2017 10-K 18 Sep 2018 2018 FY
2016 $1,265,000 +$351,000 +38% 01 Jul 2015 30 Jun 2016 10-K 15 Sep 2017 2017 FY
2015 $914,000 -$161,000 -15% 01 Jul 2014 30 Jun 2015 10-K 13 Oct 2016 2016 FY
2014 $1,075,000 -$188,000 -15% 01 Jul 2013 30 Jun 2014 10-K 13 Oct 2015 2015 FY
2013 $1,263,000 -$1,420,000 -53% 01 Jul 2012 30 Jun 2013 10-K 29 Sep 2014 2014 FY
2012 $2,683,000 01 Jul 2011 30 Jun 2012 10-K/A 04 Oct 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.